论文部分内容阅读
我院自1958年8月,开始采用抗结核药物配合奴夫卡因胸膜腔封闭,治疗结核性胸膜炎。一年来,根据临床观察,疗效显著,中毒症状迅速消失,胸液吸收较快,提高了治愈率,缩短了住院日数。茲将有完整病历记载的13例,分析如下。一、病例选择和分析的标准(一)选择病例的条件:1.临床诊断为结核性胸膜炎,经过各种检查证明为渗出性,并能除外非结核性者。2.用抗结核药物治疗,配合胸膜腔奴夫卡因封闭13例为甲组(抽液后随即注入0·25%-0.5%奴夫卡因30-50毫升),又选择13例未配合奴夫卡
Our hospital since August 1958, began to use anti-tuberculosis drugs coupled with Nufukain pleural closure, the treatment of tuberculous pleurisy. In the past year, according to the clinical observation, the curative effect was remarkable, the symptom of poisoning disappeared rapidly, the absorption of pleural fluid was quicker, the cure rate was raised and the hospitalization days were shortened. There will be a complete record of the records of 13 cases, analyzed as follows. First, the criteria for case selection and analysis (a) the conditions for the selection of cases: 1. Clinical diagnosis of tuberculous pleurisy, after a variety of tests proved to be exudative, and can exclude non-tuberculous. 2. With anti-TB drug treatment, with the pleural cavity Nuvucaine closed 13 cases of Group A (immediately after pumping fluid injection 0 · 25% -0.5% Nuvucaine 30-50 ml), and chose 13 cases not with Nuv card